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Take home message 
Investigation of MDR-TB TB outbreak with WGS was useful but whether transmission occurred was 
often inconclusive.  
 
Plain language summary 
We identified an outbreak of tuberculosis in the UK where the bacteria were resistant to the most 
effective antibiotics used to treat tuberculosis. In order to understand in whom and where 
transmission of tuberculosis was occurring, we sequenced the bacteria to compare the genetic code 
of the tuberculosis in different people in the outbreak. We found that a third of people who were in 
the outbreak had no genetic similarities in their tuberculosis. After investigating the outbreak, with 
detailed information about the patients and the bacteria, we identified that transmission occurred in 
the UK, but we could not be conclusive about whether transmission occurred in 40% of patients, 
even though the bacteria were genetically related. This paper illustrates the opportunities and 
limitations of this new technology in a drug-resistant tuberculosis outbreak.  
  
ABSTRACT 
We used whole-genome sequencing to delineate transmission networks and investigate the benefits 
of whole-genome sequencing during cluster investigation. 
 
We included clustered cases of M/XDR-TB linked by MIRU-VNTR, or epidemiological information 
in the national cluster B1006, notified between 2007-2013 in the UK. We excluded cases whose 
isolates differed by >12 SNPs from further investigation. Data relating to patients’ social networks 
were collected. 
 
Twenty-seven cases were investigated, 22 had whole-genome sequencing; 8 (36%) of which were 
excluded as their isolates differed by >12 SNPs to other cases. Eighteen cases were ruled into the 
transmission network based on genomic and epidemiological information. Evidence of transmission 
was inconclusive in 39% (7/18) of cases in the transmission network following whole-genome 
sequencing and epidemiological investigation.  
 
This investigation of a drug resistant TB cluster illustrates the opportunities and limitations of whole-
genome sequencing in understanding transmission in a setting with a high proportion of migrant 
cases. The use of WGS should be combined with classical epidemiological methods. However not 
every cluster will be solvable, regardless of the quality of genomic data.  
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INTRODUCTION 
Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern globally, with 
particularly high rates in Europe.
1
 In the UK, the number and proportion of MDR/Rifampicin
resistant-TB cases more than doubled from 38 cases (1.1%) in 2001 to 95 cases (1.8%) in 2011, and  
since decreased to 63 cases (1.7%) in 2016.
2
 A UK study of MDR-TB cases between 2004 and 2007,
combining epidemiological information from cluster investigation with 24-loci mycobacterial 
interspersed repetitive unit variable tandem repeat (MIRU-VNTR) strain typing, estimated that up to 
8.5% of UK MDR-TB cases arose from recent transmission.
3
Since January 2010, 24-loci MIRU-VNTR typing has been carried out on all culture positive 
Mycobacterium tuberculosis Complex (MtbC) isolates in the UK, and clusters of cases with 
indistinguishable strain types, which fulfil requisite criteria have been investigated to inform public 
health action.
4
As well as providing diagnostic capability to identify MtbC and determine genotypic drug resistance, 
whole-genome sequencing (WGS) can determine the genetic relatedness between strains with greater 
resolution than MIRU-VNTR.
5–8
 WGS has mainly been used retrospectively to assess transmission
networks in outbreaks, including timing and direction of transmission, rather than prospectively 
during active cluster investigations.
9–16
 In England, the roll-out of prospective WGS in routine TB
diagnostics began in December 2016 and is expected to cover the whole of England by the end of 
2017, replacing MIRU-VNTR.
17
In 2010, routine cluster review
4
 led to the investigation of a possible TB outbreak of the Beijing
strain (B1006: MIRU-VNTR 424352332517333456443372) among UK residents. Of the 231 MDR-
TB cases notified between 2010 and 2012, 27% (62) clustered with at least one other MDR-TB case 
of whom 23% (14/62) were in B1006. As this was the largest MDR-TB cluster and was only the 
second in this time period to have more than 5 cases, it was considered to be of public health 
importance.  The B1006 strain accounts for up to 25% of MDR-TB isolates tested in the Former 
Soviet Union.
18
 In November 2012, the cluster investigation status was raised to an incident,
requiring a national level incident control team to be convened to consider what action to take
4
, due
to an increase in the number of cases, including six with extensively drug resistant TB (XDR-TB), 
and the suspicion that transmission of XDR-TB was occurring in the UK. As part of this intensified 
investigation, more detailed epidemiological information was collected, and WGS was performed on 
isolates from patients. 
Here we describe the impact WGS had on the on-going cluster investigation by ascertaining whether 
the greater discrimination of WGS reduced the number of cases initially identified by MIRU-VNTR 
that required further investigation, whether a clearer understanding of the transmission chain within 
this cluster was possible combining the epidemiological links identified during the investigation and 
the WGS data, and whether WGS helped to elucidate the direction and timing of transmission. 
METHODS 
TB cases in the UK notified to the Enhanced Tuberculosis Surveillance system (ETS) were matched 
probablistically
19
 to laboratory results from culture positive isolates, including data on drug
susceptibility testing and MIRU-VNTR. ETS collects demographic, clinical, social risk factor (SRF) 
and treatment outcome data. National TB clusters (defined as at least two cases with 
indistinguishable MIRU-VNTR strain types in more than one region) were identified using bespoke 
  
software and reviewed monthly in accordance with national guidance, with cluster investigations 
launched where appropriate.
4
  
Cases of M/XDR-TB notified in the UK between 2007 and 2013 with the B1006 MIRU-VNTR 
profile (424352332517333456443372, with at least 23 complete loci), were included and referred to 
as ‘B1006 clustered cases’. Culture negative cases with a clinical diagnosis of TB and treated for 
MDR-TB who were epidemiologically linked to cluster B1006 were considered ‘probable’ clustered 
cases. MDR-TB isolates with the B1006 strain from cases prior to 2010 that had been typed 
retrospectively were also included.  
Data relating to lifestyle and social networks were collected through questionnaires case managers 
completed with their patients (Online appendix).  
A ‘confirmed’ epidemiological link was defined between two cases where either volunteered the 
name of the other as a contact, or where cases shared time in the same setting during the period when 
one of the cases were potentially infectious. A ‘probable’ epidemiological link was defined where 
both cases had spent time in the same setting, but the timing was uncertain. A ‘possible’ 
epidemiological link was defined where two cases in the same geographical area shared social or 
behavioural traits (e.g. drug use) but a specific shared setting could not be established.  
 
Cases were considered still ‘clustered’ following WGS if sequencing data differed by 129 or less 
Single Nucleotide Polymorphisms (SNPs) from another B1006 case, or if they had an 
epidemiological link to a WGS clustered case. Several SNP cut-offs previously used in tuberculosis 
investigations of 0-5
11,15
 and 0-9 were explored as alternative thresholds to assess if these better 
captured transmission.
15 
For methods on DNA preparation, whole genome sequencing and phylogenetic analysis see Online 
Appendix. 
  
 
RESULTS 
Twenty-seven cases notified in the UK between 2007 and 2013 were included in cluster B1006; 24 
of which were B1006 clustered cases and 3 were probable clustered cases (Figure 1). The majority 
were non-UK born (20/27) including 14 who were born in Lithuania, and many had a history of 
SRFs (15/27).  
 
Twenty-two patient isolates were sequenced. Of these, 8/22 (36%) isolates differed by >12 SNPs 
from all other isolates in the cluster (range 30-179 SNPs difference) (Figure 2A). As none were 
epidemiologically linked within the cluster, they were excluded from further consideration. 14 cases 
were thus linked by WGS (Figure 2B) with a further four, with no sequencing data (3 had no culture 
and 1 culture could not be re-grown) linked epidemiologically, resulting in a final cluster of 18 cases.  
 
13/18 (72%) cases had at least one SRF (drug misuse (6), alcohol misuse (5), homelessness (5), 
imprisonment (9), previous TB treatment (4)). 11/18 cases were born in Lithuania, six in the UK and 
one in South Eastern Europe. Three were children under the age of five, all born in the UK, two to 
Lithuanian parents. 12/18 (66%) cases were notified between August 2012 and August 2013, 
including 5 UK born patients, suggesting possible transmission within the UK (Figure 3). 
 
15/18 (83%) had pulmonary disease, 11 (61%) of whom were sputum smear positive. Five of the 
pulmonary cases were symptomatic for at least 6 months before starting treatment, one of whom was 
symptomatic for 2 years (LIT12), and all five had chaotic lifestyles with multiple SRFs. Two cases 
remained culture positive for more than a year after starting treatment (LIT13 and LIT24).  
  
All 15 culture confirmed cases in the cluster had isolates with phenotypic resistance to isoniazid, 
rifampicin, ethambutol, streptomycin and kanamycin. There were differences in drug susceptibility 
testing (DST) for pyrazinamide, prothionomide, ethionomide, moxifloxacin and ofloxacin (Figure 
3). The 8 cases in Region A and Region C shared the same DST profile and had pyrazinamide 
resistance; the 3 cases in Region D shared the same profile and were sensitive to pyrazinamide. The 
four XDR-TB cases in Region B had resistance to moxifloxacin and ofloxacin, 3 of whom were also 
resistant to prothionamide and ethionamide. 
 
Potential transmission networks 
Amongst the 14 cases with isolates within 12 SNPs of each other, each was genomically linked to 
between 6 and 13 people, but there was clear sub-clustering within each geographic region (Figure 
2B and 2C).  
 
Using the 5 SNP threshold suggested there were three unlinked local outbreaks (Figure 4A). 
Increasing the threshold to 9 SNPs (Figure 4B) suggested transmission may have been more 
widespread between Region A, Region B and Region C, and increasing the threshold to 12 SNPs 
suggested transmission may have occurred across all geographical areas (Figure 2C). 
 
By combining the epidemiological information, DST profiles, and genomic data, potential 
transmission networks were identified in four regions of England (Figure 5).  
 
In Region A (Figure 5A), despite the low number of SNPs between cases, epidemiological links 
could not be identified; it was therefore inconclusive as to whether recent transmission had occurred. 
The first case was UK born, had extra-pulmonary TB, and shared no distinctive characteristics with, 
  
or epidemiological links to, the other cases in Region A. Her isolate was 2 and 4 SNPs from that of 
two Lithuanian cases. 
 
In Region B (Figure 5B), there was one probable epidemiological link between two cases who had 
lived together (timing and location unknown) but their isolates had 12 SNPs difference and different 
DST profiles, making direct transmission unlikely. Evidence for transmission between the four 
XDR-TB cases was inconclusive as the epidemiological, microbiological and genomic data were not 
supportive.  
 
In Region C (Figure 5C), all cases with WGS were 5 or fewer SNPs from at least one other case. 
The epidemiological data linking patients by household, workplace, and hospital were suggestive of 
transmission. The most parsimonious interpretation of the phylogeny suggested LIT08 may have 
transmitted to LIT20 and LIT21, and that LIT20 may have transmitted to LIT09 (Figure 2A,B). 
However, closer inspection of the sequence data suggests LIT08 is more likely to have been the 
source of both LIT20 and LIT09, as the variant distinguishing these two sequences from LIT08 is 
present as a minority allele in LIT08. The epidemiological information did not support LIT20 
transmitting to LIT09 but supported the interpretation of the variants that LIT09 was likely to have 
been infected by LIT08 (the child’s parent). 
 
In Region D (Figure 5D), both the WGS and epidemiological data were suggestive of transmission. 
Isolates were 0 SNPs apart, and the cases were linked through their households. The direction of 
transmission was inferred from the epidemiological data, but as there were 0 SNP differences 
between isolates, no additional information relating to the direction of transmission could be 
determined by the WGS results. 
  
Identification of epidemiological links and transmission settings: added value of WGS in this cluster 
investigation  
A total of 24 epidemiological links between cases were identified (Table 1), 8 (33%) through routine 
contact tracing (7 household contacts, 1 relative) and an additional 16 epidemiological links (1 
prison, 2 work, 2 neighbours, 1 probable previous household (HH), 9 possible work/drug use 
contact) following MIRU-VNTR cluster investigation. Two of the 8 links that were identified 
through routine contact tracing and 5/16 links identified following MIRU-VNTR results were 
confirmed by WGS. The remaining 7 links identified through MIRU-VNTR investigation had more 
than 5 SNPs between them and were thus unclear and two had more than 12 SNPs and were thus 
refuted by WGS.  Two new settings were identified (a work place and a hospital). Public health 
actions were undertaken at the work place, but no new cases were identified. 
 
 
Table 1: Epidemiological links identified following action taken (contact tracing, MIRU-VNTR cluster investigation and WGS). Red shading refers to “Link 
identifed following”, orange “Link confirmed by”, blue “Link queried by” and Green “Link refuted by” 
Potential link identified by Cluster investigation epidemiological link 
CASES LINKED 
CONTACT 
INVESTIGATION 
MIRU-VNTR CLUSTER 
INVESTIGATION 
WGS 
STRENGTH 
OF LINK 
TYPE OF CONTACT SETTING OF CONTACT 
LIT10-LIT26 Yes Confirmed Confirmed 0 SNPs Known Relative Household 
LIT08-LIT09 Yes Confirmed Confirmed 3 SNPs Known Relative (Parent-child) Household 
LIT08-LIT23 Yes No culture for either No culture for either Known Relative (Husband-Wife) Household 
LIT08-LIT22 Yes No culture for either No culture for either Known Household 
LIT23-LIT09 Yes No culture for one No culture for one Known Relative (Parent-chilld) Household 
LIT23-LIT22 Yes No culture for one No culture for one Known Household 
LIT09-LIT22 Yes No culture for one No culture for one Known Household 
LIT24-LIT27 Yes No culture for one No culture for one Known Relative (Parent-child) Do not live together 
LIT06-LIT07 No Yes No growth for one Known Prison 
LIT08-LIT20 No Yes Confirmed 1 SNP Probable Work contact Work 
LIT23-LIT20 No No culture for one No culture for one Probable Work contact Work 
LIT24-LIT26 No Yes Confirmed 0 SNPs Probable Neighbours 
LIT10-LIT24 No Yes Confirmed 0 SNPs Probable Neighbours 
LIT09-LIT21 No Yes (query contamination) Confirmed 5 SNPs Probable Hospital 
LIT12-LIT02 No Yes Queried 12 SNPs Probable Friends Previous household  (timing not known) 
LIT06-LIT12 No Yes Confirmed 4 SNPs Possible Construction in Region A 
LIT02-LIT13 No Yes Queried 10 SNPs Possible Agricultural work 
LIT02-LIT14 No Yes Queried 12 SNPs Possible Cannabis use/agricultural work 
LIT14-LIT13 No Yes Queried 12 SNPs Possible Agricultural work 
LIT06-LIT08 No Yes Queried 6 SNPs Possible Construction in Region A 
LIT12-LIT08 No Yes Queried 6 SNPs Possible Construction in Region A 
LIT14-LIT01 No Yes Queried 8 SNPs Possible Cannabis use/agricultural work 
LIT02-LIT01 No Yes Refuted 16 SNPs Possible Cannabis use/agricultural work 
LIT01-LIT13 No Yes Refuted 16 SNPs Possible Agricultural work 
  
DISCUSSION  
A large M/XDR-TB cluster was identified in the UK by MIRU-VNTR strain typing, enabling 
prompt cluster investigation. Detailed analyses of epidemiological and genomic data provided strong 
evidence transmission had occurred in the UK. Consistent with recognised limitations of MIRU-
VNTR for the Beijing lineage 
20
, the use of WGS allowed discrimination between cases clustered by 
MIRU-VNTR and the exclusion of one-third of cases from the investigation. This allowed resources 
to be focused on the investigation of cases that were more likely to have been part of the same 
transmission network.  
As well as the evidence WGS provided to refute transmission MIRU-VNTR had identified, WGS 
also provided corroborative evidence that transmission was likely to have occurred in a small number 
of cases, who had either confirmed or probable epidemiological links. In most cases the WGS data 
were consistent with the combined findings from MIRU-VNTR and epidemiological investigation. 
In one instance WGS suggested transmission could have occurred (separated by 2 and 4 SNPs to 
other cases), yet this seemed epidemiologically implausible as the case with earliest symptom onset 
had extra-pulmonary TB, and no known links with two subsequent cases. One possible explanation 
may be the presence of unknown intermediary cases.  
Whilst there are anecdotal data where phylogeny have indicated the direction of transmission in TB 
outbreaks,
15
 this analysis also underscores the importance of exploring the raw sequence data at 
variant sites. During the active investigation of this cluster, and in the routine use of WGS data in 
cluster investigation, only the phylogenetic tree was used to direct public health action. Only after 
the incident, when trying to understand why the tree and epidemiological data were inconsistent did 
we find the presence of a variant allele seen in secondary strains, as a minority allele in an ancestral 
strain. This deeper analysis of the sequence data concorded with the epidemiological data to 
understand the possible direction of transmission between cases in this cluster as was recently 
  
demonstrated by Worby et al in other pathogens.
21
 The addition of WGS did not facilitate the 
identification of additional links or missing cases identified in this setting.   
The most effective SNP threshold to apply in practice to most efficiently identify transmission 
networks in tuberculosis has previously been discussed.
16–18,22
 While our results suggest that 
identifying large numbers of SNPs between isolates is extremely helpful for refuting transmission, 
we found that the 12 SNP cut-off is likely to over-estimate recent transmission, for example 
significant inter-regional transmission in this cluster looked didn’t look plausible and small SNP 
differences between isolates did not always lead to the identification of epidemiological links, as was 
also recently shown in a large isoniazid cluster in London.
22
 Although distances of a 0-2, or even 0-5 
SNPs would normally suggest a high probability of recent transmission, this outbreak highlights the 
need to remain aware of exceptions to this, particularly when a large number of cases occur in 
migrants whose disease may be due to reactivation of distantly acquired infection.  Other factors may 
also affect the assessment of transmission through SNP differences such as clinical disease 
manifestation, duration of infection, patient bacterial load, antibiotic therapy, acquisition of drug 
resistance and actual infective dose which would need building into any model using SNP number to 
predict transmission events. 
 
Many of the patients in this cluster had chaotic lifestyles and multiple risk factors associated with 
delayed diagnosis and poor adherence to treatment, plausibly contributing to further transmission of 
this strain. Cluster investigation in populations with a high number of risk factors and drug resistant 
TB requires considerable resources. The lifestyles of some of the cases in this cluster presented a 
challenge to TB control, as it was difficult to collect epidemiological information, and indeed 
epidemiological links between cases who were genotypically linked may not have been identified in 
this cluster. Such investigations can be resource intensive, but to prevent transmission of TB, 
  
including of drug resistant TB, in high risk groups, cluster investigation remains a key component of 
disease control. 
Routine cluster investigation based on MIRU-VNTR was recently scaled back in the UK, in part due 
to a lack of evidence on its cost effectiveness in preventing further transmission, and in part due to a 
lack of available resources.
23
 Frequently considerable time and resources were invested without 
identifying additional epidemiological links, transmission settings or cases. This may be in part due 
to MIRU-VNTR not being able to adequately distinguish clusters in some TB lineages or due to the 
high proportion of imported TB cases who reactivate in the UK.
24
 Other low incidence settings have 
found similar issues relating to the specificity of MIRU-VNTR.
25
 To address this concern, a more 
targeted approach for flagging high risk national MIRU-VNTR clusters by running a red flag 
algorithm to identify priority clusters, including clusters with cases with MDR-TB for review, was 
developed in England. Furthermore, due to the poor resolution of MIRU-VNTR for some TB 
lineages
20
 and high levels of clustering in non-UK born patients with no identified epidemiological 
links, many clusters with predominantly non-UK born populations in the UK have been assumed to 
represent common imported strain types and investigation has not been prioritised. The results from 
this analysis show transmission may be occurring in the UK in a subset of these clusters. Recent 
analysis suggests WGS is cost effective due to the parallel identification of drug resistant strains.
5
 
Due to the ability of WGS to predict drug resistance and its greater resolution, replacement of 
MIRU-VNTR typing may be cost effective. Modelling the cost per quality adjusted life year gained 
with this technology would be useful.  
WGS is now being used routinely in the TB diagnostic pathway in England
26
; potential benefits will 
include faster results for speciation of mycobacteria, prediction of drug susceptibility and relatedness 
of cases in a single process
5
. The long term systematic use of WGS should also enable better analysis 
of transmission dynamics at a population level in England than was possible with MIRU-VNTR, in 
  
order to monitor the impact of policy changes on transmission
27,28
. As the roll-out of WGS is 
underway, clinical and public health teams have begun to make use of this new technology 
describing both the benefits in an XDR-TB cluster in London and the limitations in a large isoniazid 
resistant cluster in London.
22,29
  
 
Bayesian inference methods, which combine information on SNP differences between isolates, time 
to nearest common ancestor, and epidemiological data, are likely to be of benefit for helping to 
understand possible transmission networks, and to inform public health action.
30
 If automated 
algorithms could be applied, combining WGS data and epidemiological data informed by highly 
predictive models, cluster investigation may be considered in middle and other high income settings. 
In resource poor settings where TB transmission is likely to be more common, little use of real-time 
cluster investigation has occurred largely due to lack of available resources. 
 
The introduction of universal WGS in England will undoubtedly revolutionise testing for antibiotic 
resistance
26
. In addition, using WGS in this cluster investigation provided evidence that a third of the 
cases identified on the basis of this MIRU-VNTR type were not plausibly part of the same 
transmission network, thus enabling us to focus additional investigative resources on a smaller 
number of cases, and provided supportive evidence transmission had occurred in a small number of 
cases with confirmed epidemiological links. Despite the obvious increase in granularity of WGS 
data, the evidence of whether some cases in this cluster were part of the transmission chain was 
inconclusive, especially in non-UK born cases. These data suggest that, as was seen using MIRU-
VNTR, WGS in combination with epidemiological investigations may not enable the determination 
of whether recent, and hence UK-based, transmission has occurred in all cases. This study 
emphasises the importance of the use of classical epidemiological methods; a significant proportion 
of the epidemiological links we identified were as a result of routine contact tracing. The use of 
  
genotyping data alone, whether that be MIRU-VNTR or WGS, likely over-estimates transmission, 
resulting in inconclusive determination of networks. Whilst WGS is best viewed as a tool that directs 
epidemiological investigations with optimal precision, future research should evaluate the impact of 
WGS use on subsequent public health action and detection of previously unrecognised cases in 
cluster investigation.  This may allow the re-initiation of routine prospective cluster investigations in 
resource rich, low incidence settings approaching tuberculosis elimination. 
 
 
Declarations of interest 
FD and NC were supported by the Imperial BRC. All other authors declare they have no financial or 
other conflict of interest. 
Ethics approval and consent to participate 
Public Health England has authority under the Health and Social Care Act 2012 to hold and analyse 
national surveillance data for public health and research purposes. 
Author’s contributions 
MKL, HLT and IA conceived and designed the study. MKL, LFA, JAD, NR, CM, MG, KF and FD 
collected data for the study. TW, NC conducted sequencing and sequencing analysis for the study. 
MKL carried out the analysis and writing of the manuscript. TB, JM, AB and FD provided isolates 
for the study. All authors were involved in the incident, contributed to the design of the analysis and 
commented on manuscript versions. All authors have read and approved the final version of this 
manuscript. 
  
 
Funding source 
This study was supported by Public Health England, no external funding was received. 
  
  
 
In Region A (Figure 5A), the first case (LIT99) was UK born, had extra-pulmonary TB, and no 
SRFs. She shared no distinctive characteristics with, or epidemiological links to, the other cases in 
Region A, despite her isolate being separated by only 2 and 4 SNPs from isolates from two of the 
Lithuanian cases. The low number of SNPs is consistent with presumed recent transmission, 
however, given that the first case had extra-pulmonary TB and there was no supporting 
epidemiological evidence it is unlikely she was the source of infection for the subsequent cases. 
There was one known epidemiological link between two prisoners, but only one had WGS results. 
The three Lithuanian cases whose isolates were separated by 4-6 SNPs had all worked in the 
construction industry, although it is unknown whether they ever encountered each other. All cases 
had the same phenotypic DST profile.  
 
In Region B (Figure 5B), there was one probable epidemiological link between two cases who had 
lived together at some point (timing and location of shared residency unknown); these cases had 12 
SNPs difference between isolates, and they had different DST profiles. All four XDR-TB cases in 
this location worked in the agricultural industry for agencies with frequent job changes; three of 
them reported smoking cannabis and three had been in prison in Lithuania, although at different 
times to each other. The XDR cases had all previously been treated for TB, 3 on more than one 
occasion in Lithuania (strain type and sensitivities of initial treatment unknown). The four XDR-TB 
cases had between 8 and 12 SNPs between their isolates and two had different resistance profiles. No 
confirmed epidemiological links between them could be identified. Evidence for transmission of 
XDR-TB was therefore inconclusive as the epidemiological, microbiological and genomic data were 
not supportive when combined.  
In Region C (Figure 5C), the first four cases notified were within two families who shared a house. 
Another case was linked to the workplace where the adults in the household worked and a further 
  
UK born case was treated in the same hospital that the other cases were treated at, but no definitive 
setting or timing was identified. All cases with WGS results in Region C were 5 or fewer SNPs apart 
from at least one other case in Region C, confirming the epidemiological evidence for transmission. 
The most parsimonious interpretation of the phylogenetic tree suggested that LIT08 is likely to have 
transmitted to LIT20 and LIT21 and that LIT20 is likely to have transmitted to LIT09 (Figure 
2A,B). However, closer inspection of the sequence data suggests LIT08 is more likely to have been 
the source of both LIT20 and LIT09, as the variant distinguishing these two sequences from LIT08 is 
present as a minority allele in LIT08. The epidemiological information did not support LIT20 
transmitting to LIT09 but supported the interpretation of the variants that LIT09 was likely to have 
been infected by LIT08 (the child’s parent). 
 
In Region D (Figure 5D), the first two cases notified lived close to each other with indistinguishable 
isolates. However, despite intensive investigations, no common setting or evidence that they knew 
each other was identified. General awareness raising of signs and symptoms of TB and information 
about local TB services was undertaken with services for vulnerable groups but no active case 
finding was undertaken. Two further cases were household contacts of the first and second cases, and 
the isolate of the household contact of the first case was indistinguishable to the first case. No sample 
was taken from the other household contact. The WGS results supported the epidemiological data 
that transmission had occurred. The direction of transmission was inferred from the epidemiological 
data, but as there were 0 SNP differences between isolates, no additional information relating to 
timing or the direction of transmission could be determined by the WGS results.  
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Figure Legends 
Figure 1: Flow chart of cases in cluster B1006 
Initial intensified investigation (n=27). 18 cases remained under investigation (highlighted in red) 
following WGS results, which included 14 clustered cases with <12 SNPs between each case and 
another case, 3 probable clustered cases with no culture (or WGS) who were epidemiologically 
linked to cases in the cluster, and 1 clustered case with MIRU-VNTR B1006, but no WGS epi linked 
to another case in the cluster. 
Figure 2: A) Phylogenetic tree showing genetic diversity between isolates sequenced from 22 
cases in cluster B1006. Red selection shows isolates that are a maximum of 12 SNP differences 
from at least one other isolate in the cluster. B) Phylogenetic tree of isolates, sequenced from 14 
cases, with 12 or less SNP differences from at least one other isolate in the cluster. Black 
numbers represent the number of SNPs, red numbering represents order of cases in terms of onset of 
symptoms. Green place names show geographical location of cases. C) Table of SNP differences 
between isolates, sequenced from 14 cases, with 12 or less SNP differences from at least one 
other isolate in the cluster. Red highlighting represents 0-5 SNPs, yellow represents 6-12 SNPs and 
white represents 13-16 SNPs. The final two columns show how many cases the case is linked to 
using 5 or 12 SNP cut offs. 
 
Figure 3: Time-line showing characteristics cases in B1006 with onset of symptoms until the 
start of MDR-TB treatment  
Figure 4: Cluster diagram showing epidemiological links and WGS data nationally, A] showing 
SNPs <=5, B] showing SNPs <=9 (legend as in Figure 5) 
 
Figure 5: Cluster diagram showing epidemiological links and WGS data within four areas  
  
Footnotes 
Foot note for Figure 5: 
Cases who spent time in more than one geographical area are presented in each region.  
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ID LIT99 LIT12 LIT06 LIT10 LIT02 LIT14 LIT13 LIT01 LIT09 LIT08 LIT20 LIT21 LIT24 LIT26 ≤ 5 SNPs ≤ 12 SNPs
1 LIT99 na 4 2 10 12 6 12 10 9 6 7 8 10 10 2 13
2 LIT12 4 na 4 10 12 6 12 10 9 6 7 8 10 10 2 13
3 LIT06 2 4 na 10 12 6 12 10 9 6 7 8 10 10 2 13
4 LIT10 10 10 10 na 16 10 16 14 13 10 11 12 0 0 2 9
5 LIT02 12 12 12 16 na 12 10 16 15 12 13 14 16 16 0 6
6 LIT14 6 6 6 10 12 na 12 8 9 6 7 8 10 10 0 13
7 LIT13 12 12 12 16 10 12 na 16 15 12 13 14 16 16 0 6
8 LIT01 10 10 10 14 16 8 16 na 13 10 11 12 14 14 0 7
9 LIT09 9 9 9 13 15 9 15 13 na 3 2 5 13 13 3 7
10 LIT08 6 6 6 10 12 6 12 10 3 na 1 2 10 10 3 13
11 LIT20 7 7 7 11 13 7 13 11 2 1 na 3 11 11 3 11
12 LIT21 8 8 8 12 14 8 14 12 5 2 3 na 12 12 3 11
13 LIT24 10 10 10 0 16 10 16 14 13 10 11 12 na 0 2 9
14 LIT26 10 10 10 0 16 10 16 14 13 10 11 12 0 na 2 9
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Online appendix: 
Lifestyle and social network data collection 
Interpreters were used when required, and patients were re-interviewed when further 
information was required. Questions included details of settings visited in the previous two 
years, including educational institutions, workplaces, places of worship, social settings (e.g. 
pubs/bars/clubs), prisons, rehabilitation centres, hostels/homeless shelters, and hospitals. 
Further questions were asked on any previous exposure to TB, travel within the UK or 
abroad, having visitors from abroad or elsewhere in the UK, and previous addresses of 
residence. Additional information relating to previous treatment abroad was collected where 
possible by contacting clinical or public health colleagues in the countries of origin. 
Following the review of all available data, cases were asked additional questions about 
specific possible transmission settings that had been identified.  
DNA preparation, Whole Genome Sequencing and phylogenetic analysis  
Isolates from 22 cases that met the confirmed MIRU-VNTR clustered case definition were 
available for sequencing. Results from the epidemiological investigation and those from 
WGS were held separately and compiled once the phylogenetic trees had been produced. 
Methods were as previously described
9
.  Briefly, cultures were grown in Becton-Dickinson 
Mycobacterial Growth Indicator Tubes containing modified Middlebrooks 7H9 liquid 
medium and on Löwenstein-Jensen agar. DNA was extracted and purified using the Fuji 
Quickgene kit (Fuji-Sciences, France) with an added mechanical disruption step using the 
MP Biomedicals Fastprep homogeniser and Lysing Matrix B. Isolates were sequenced on the 
Illumina MiSeq platform at the Wellcome Trust Centre for Human Genetics in Oxford and on 
the Illumina Genome Analyzer GAII or HiSeq 2000 at the Wellcome Trust Sanger Institute. 
  
Sequence reads were processed against the rv37 M.tuberculosis reference strain in both 
Oxford and the Public Health England National Mycobacterial Reference Laboratory for 
comparison. Results presented in this paper were those obtained from the Oxford university 
pipeline. The phylogenetic tree was visualized with FigTree 
(tree.bio.ed.ac.uk/software/figtree).  
 
 
 
 
 
 
 
 
 
